JESSICA DELCORVO: Open Payments
NPI 1003223355 · LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,342 in 74 payments from 14 companies in 2025. Trend: 2023 $587 · 2024 $838 · 2025 $1,342
Food & beverage: $1,342
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $311 |
| Novartis Pharmaceuticals Corporation | 11 | $143 |
| E.R. Squibb & Sons, L.L.C. | 6 | $129 |
| Alnylam Pharmaceuticals Inc. | 4 | $118 |
| Merck Sharp & Dohme LLC | 5 | $93 |
| Boston Scientific Corporation | 3 | $89 |
| Actelion Pharmaceuticals US, Inc. | 3 | $87 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 10 | $85 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $72 |
Products named: ELIQUIS, LEQVIO, VYNDAQEL, ONPATTRO, CAMZYOS, VERQUVO, WATCHMAN FLX, OPSUMIT.
Industry payments across MI — which companies pay providers there.
